Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy
Analytical Cellular Pathology · 2023
DOI: 10.1155/2023/9849719 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical Cellular Pathology, 2023. Verfasst von Ziyuan Que und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yangzhou University Medical College, Yangzhou University, Yangzhou 225009, Jiangsu Province, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant bone neoplasms can be represented by osteosarcoma (OS), which accounts for 36% of all sarcomas. To reduce tumor malignancy, extensive efforts have been devoted to find an ideal target from numerous candidates, among which RNA‐binding proteins (RBPs) have shown their unparalleled competitiveness. With the special structure of RNA‐binding domains, RBPs have the potential to establish relationships with RNAs or small molecules and are considered regulators of different sections of RNA processes, including splicing, transport, translation, and degradation of RNAs. RBPs have considerable significant roles in various cancers, and experiments revealed that there was a strong association of RBPs with tumorigenesis and tumor cell progression. Regarding OS, RBPs are a new orientation, but achievements in hand are noteworthy. Higher or lower expression of RBPs was first found in tumor cells compared to normal tissue. By binding to different molecules, RBPs are capable of influencing tumor cell phenotypes through different signaling pathways or other axes, and researches on medical treatment have been largely inspired. Exploring the prognostic and therapeutic values of RBPs in OS is a hotspot where diverse avenues on regulating RBPs have achieved dramatical effects. In this review, we briefly summarize the contribution of RBPs and their binding molecules to OS oncogenicity and generally introduce distinctive RBPs as samples. Moreover, we focus on the attempts to differentiate RBP’s opposite functions in predicting prognosis and collect possible strategies for treatment. Our review provides forwards insight into improving the understanding of OS and suggests RBPs as potential biomarkers for therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yangzhou University Medical College, Yangzhou University, Yangzhou 225009, Jiangsu Province, China.
- Department of Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, Zhejiang, China.
ORCID-Profile: Ziyuan Que, Kang Yang
Zitieren
APA
Que, Z., Yang, K., Wang, N., Li, S., & Li, T. (2023). Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy. Analytical Cellular Pathology. https://doi.org/10.1155/2023/9849719
Vancouver
Que Z, Yang K, Wang N, Li S, Li T. Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy. Analytical Cellular Pathology. 2023. doi:10.1155/2023/9849719
BibTeX
@article{Que2023,
author = {Que, Ziyuan and Yang, Kang and Wang, Nan and Li, Shuying and Li, Tao},
title = {Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy},
journal = {Analytical Cellular Pathology},
year = {2023},
doi = {10.1155/2023/9849719}
}
EUVIMED